Drug expenditures in oncology have risen faster than in other areas of health care. While health gains have been made in the treatment of cancer with new therapies, there is concern among policy makers and health care providers that the high costs for new cancer treatments might not be justified (more…)
Today, January 4th 2015, the Canadian Cancer Society has published their Top 10 CCS-Funded Research Stories for 2015: click here for details. ARCC is very proud to announce that one of our ARCC Investigators, Dr. Lisa Barbera has been featured this year for her May 2015 Publication in the Journal of (more…)
Thank you Dr. Jeffrey Hoch In November 2015, Dr. Jeffrey Hoch stepped down from his role as Co-Director of the Canadian Centre for Applied Research in Cancer Control (ARCC). Dr. Hoch is an original ARCC Co-Founder, and has helped lead ARCC since 2009. During that time the ARCC Network has (more…)
Nominations are now being accepted for two prestigious awards for outstanding achievement in the field of health technology assessment (HTA) in Canada. Do you know someone who has been a leader and champion of health technology assessment (HTA) over many years, or perhaps a (more…)
ARCC Investigator and Professor at the University of British Columbia, Dr. Michael M. Burgess will share his research on why deliberative public engagement is best used when the scale and urgency of policy decisions justify the expense and effort. Dr. Burgess is the next speaker in lecture series hosted by CADTH which (more…)
TO REGISTER FOR THIS WEBINAR: Contact Saima – saima.memon@partnershipagainstcancer.ca The Data Use and Publications Committee (DUPC), a subcommittee of the Canadian Council of Cancer Registries, in partnership with the Canadian Partnership Against Cancer (CPAC), is pleased to announce an upcoming webinar focusing on CPAC’s Cancer Risk Management Model (CRMM) on (more…)
The CADTH Drug Portfolio Information Sessions are an opportunity to receive an update on CADTH’s Drug Portfolio, including the Common Drug Review (CDR), the pan-Canadian Oncology Drug Review (pCODR), Therapeutic Reviews, and the Rapid Response program. CADTH’s Patient Engagement Strategy, Scientific Advice Program, and the alignment of CDR and pCODR (more…)
The 2016 CADTH Symposium Program Committee invites submissions of abstracts for workshops, panels, breakfast sessions, and oral and poster presentations, related to the theme of Evidence for Everyone: Expanding the Reach of Health Technology Assessment. Abstracts must be submitted online at Call for Abstracts. Submission Deadline: Friday, Oct 30, 2015 (more…)
Help improve patient and public engagement in economic evaluations!March 31, 2026 - 11:21 am
**NEW** CIHR Institute of Cancer Research and ARCC Research Impact AwardsJanuary 14, 2026 - 7:54 am
CCS Research Training Awards 2024December 27, 2023 - 2:37 pm
Patient perspectives of Value Frameworks used to Guide Oncology Treatment DecisionsMay 1, 2021 - 12:27 pm
CCS Research Training Awards – PhD Students/Postdoctoral FellowsMay 14, 2026 - 3:32 pm
Welcoming Dr. Kednapa Thavorn as Co-Director of ARCCMay 4, 2026 - 8:06 amHelp improve patient and public engagement in economic evaluations!March 31, 2026 - 11:21 am
Connect With Us!